Metabiomed Co Ltd
KOSDAQ:059210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CreditAccess Grameen Ltd
NSE:CREDITACC
|
IN |
|
H
|
Hengbo Holdings Co Ltd
SZSE:301225
|
CN |
|
C
|
Carrier Global Corp
XETRA:4PN
|
US |
|
K
|
Korea Computer Terminal Inc
KOSDAQ:089150
|
KR |
|
C
|
Chongqing Jianshe Vehicle System Co Ltd
SZSE:200054
|
CN |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
|
CN |
|
Caleffi SpA
MIL:CLF
|
IT |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
115.6B KRW |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.7T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
28.9B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
95.8B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.9B USD |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
43B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
977.2B JPY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.7B CNY |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Metabiomed Co Ltd
Glance View
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Metabiomed Co Ltd is 12.9%, which is above its 3-year median of 11.2%.
Over the last 3 years, Metabiomed Co Ltd’s Net Margin has increased from 11.7% to 12.9%. During this period, it reached a low of 3.6% on Dec 31, 2023 and a high of 18.8% on Mar 31, 2025.
